FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to a depot form containing a somatostatin analogue, a biologically degradable polymer as an active component where polymer is a linear or branched copolymer of lactide and glycolide, polyethylene glycol dialkyl ester, a pharmaceutically acceptable organic solvent, as well as to a method for making the depot form.
EFFECT: invention provides prolonged release of an active agent and prolonged sediment-free storage.
14 cl, 7 ex, 1 tbl
